Generation Bio Co.
GBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 108.4% | -91.2% | 108.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 11.9% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -258.2% | -2,780.1% | -164.3% | -448.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -346.3% | -2,735% | -169.7% | -510.6% |
| EPS Diluted | -0.82 | -3.12 | -2.21 | -3.2 |
| % Growth | 73.7% | -41.2% | 30.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |